Stanford, CANCT04615546Now EnrollingIRB Ready

Post-Bariatric Hypoglycemia Clinical Trial in Stanford, CA

Access cutting-edge post-bariatric hypoglycemia treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.

Sponsored by Stanford University

Quick Self-Assessment

See if you qualify for this Stanford location

Preparing your pre-screening questions…

Expert Care in Stanford

Access post-bariatric hypoglycemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related post-bariatric hypoglycemia treatment provided free

Apply for This Stanford Location

Check if you qualify for this post-bariatric hypoglycemia clinical trial in Stanford, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stanford

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stanford site if eligible
  4. 4Begin participation

About This Post-Bariatric Hypoglycemia Study in Stanford

Severe hypoglycemia (low blood sugar)after gastric bypass surgery is an increasingly recognized condition, characterized by symptoms of hypoglycemia after eating and inappropriately elevated insulin concentrations that occur at the time of hypoglycemia. Severe hypoglycemia can be dangerous and debilitating and can also impact cognitive function. At the moment no medical therapies have been developed for this disorder. Determining why some but not other patients develop this condition would allow for improved prediction, prevention, and treatment approaches. The purpose of the study is to understand the physiological changes observed in those patients who undergo gastric bypass and develop symptomatic hypoglycemia.

Sponsor: Stanford University

Who Can Participate

Inclusion Criteria

Male or female patients 18-70 years of age
Post-bariatric surgery more than 6 months prior to signing the informed consent (not required for non-surgical controls)
Documented history of hyperinsulinemic hypoglycemia (not required for post-bariatric and non-surgical controls)

Exclusion Criteria

Patients currently using sulfonylureas or other medications that may interfere with glucose metabolism within 5 half-lives of drug.
Participation in any clinical investigation within 4 weeks prior to dosing
History of or current insulinoma
Active infection or significant acute illness within 2 weeks prior to dosing
Female patients who are pregnant or lactating
Women of childbearing potential and not utilizing effective contraceptive methods
Inadequate end organ function as defined by: Serum creatinine \>2.0 mg/dL, alanine transaminase (ALT) and aspartate aminotransferase (AST) \> 2 x Upper Normal Limit
Allergy to test meal or medications used in the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stanford?

Yes, this clinical trial (NCT04615546) has an active research site in Stanford, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Post-Bariatric Hypoglycemia Treatment Options in Stanford, CA

If you're searching for post-bariatric hypoglycemia treatment options in Stanford, CA, this clinical trial (NCT04615546) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced post-bariatric hypoglycemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all post-bariatric hypoglycemia clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Stanford, CA

See all heart attack clinical trials recruiting in Stanford — not just this study.

Browse Heart Attack Trials in Stanford →

Ready to Join in Stanford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stanford, CA